The inhibition of goldthioglucose and bipiperidyl mustard-induced hypothalamic lesions by anti-inflammatory agents.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D005947:Glucose / Q000037:antagonists & inhibitors*; D006046:Gold / Q000037:antagonists & inhibitors*; D006493:Heparin / Q000494:pharmacology; D006854:Hydrocortisone / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D051379:Mice; D009150:Mustard Compounds / Q000037:antagonists & inhibitors*; D011748:Pyrogallol / Q000494:pharmacology; D012459:Salicylates / Q000494:pharmacology; D012965:Sodium Chloride / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D009150:Mustard Compounds; D012459:Salicylates; D011748:Pyrogallol; D012965:Sodium Chloride; D006046:Gold; D001285:Atropine; D006493:Heparin; D005947:Glucose; D001241:Aspirin; D002746:Chlorpromazine; D006854:Hydrocortisone; D007213:Indomethacin